CopyFind
Meprate 2.5 Tablet
medicine 📍 IN

Meprate 2.5 Tablet

20,45 ₹

Analogs of Meprate 2.5 Tablet

Find cheaper analogs and generic equivalents for Meprate 2.5 Tablet.

Ingredients

Wirkstoff: Medroxyprogesterone acetate


Produktübersicht

About Meprate 2.5 Tablet

Meprate 2.5 Tablet is a medication containing the active ingredient Medroxyprogesterone acetate, classified as Injectable form of birth control. Medroxyprogesterone acetate (MPA), whose injectable form is known as depot medroxyprogesterone acetate (DMPA) and sold under the brand name Depo-Provera among others, is a hormonal medication of the progestin type.

Key Benefits & Uses

  • Used for: 1 INDICATIONS AND USAGE Medroxyprogesterone acetate injectable suspension is indicated for use by females of reproductive potential to prevent.
  • Used for: Limitations of Use: The use of medroxyprogesterone acetate injectable suspension is not recommended as a long-term (i
  • Use only as directed on the product label or by a healthcare professional.

Active Ingredient & Action

Medroxyprogesterone acetate, the active ingredient in Meprate 2.5 Tablet, belongs to the Injectable form of birth control class. 1 INDICATIONS AND USAGE Medroxyprogesterone acetate injectable suspension is indicated for use by females of reproductive potential to prevent pregnancy. Limitations of Use: The use of medroxyprogesterone acetate injectable suspension is not recommended as a long-term (i. e. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Meprate 2.5 Tablet. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Meprate 2.5 Tablet for extended periods without medical advice.

Find in Pharmacies

Compare local prices and distance for Meprate 2.5 Tablet.

Visitor ratings

Help others by rating how useful this product page is.

No ratings yet — be the first.